From October 1, 2022 to December 31, 2022, the company has repurchased 4,000 shares, representing 0.009061% for ¥8.97 million. With this, the company has completed the repurchase of 203,900 shares, representing 0.46% for ¥419.21 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,078 JPY | +2.82% | +1.76% | +3.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.02% | 568M | |
+20.37% | 43.39B | |
+19.44% | 22.01B | |
+18.63% | 15.46B | |
+25.55% | 14.93B | |
+60.99% | 13.13B | |
-0.05% | 6.79B | |
-15.02% | 6.36B | |
-8.87% | 5.73B | |
+10.57% | 5.43B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.